Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ CBP20 Protein
SDP

Catalog No. NBP14943501 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
0.5 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP14943501 0.1 mg
NBP1494355 0.5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. NBP14943501 Supplier Novus Biologicals™ Supplier No. NBP1494350.1MG
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results.

A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 1-156 of Human CBP20 The Recombinant Human CBP20 Protein is derived from E. coli. The Recombinant Human CBP20 Protein has been validated for the following applications: SDS-Page.

Specifications

Accession Number NP_031388
Concentration 0.5mg/mL
For Use With (Application) ELISA, SDS-PAGE
Formulation 20mM Tris-HCl buffer (pH 8.0) containing 20% glycerol, 0.1M NaCl, 1mM DTT
Gene ID (Entrez) 22916
Molecular Weight (g/mol) 20.1kDa
Purification Method Protein
Quantity 0.1 mg
Source Recombinant human NCBP2 protein, fused to His-tag at N-terminus, expressed in E. coli
Immunogen NCBP2, 1-156aa, Human, His tag, E. coli (NP_031388).
Storage Requirements Store at -80°C. Avoid freeze-thaw cycles.
Regulatory Status RUO
Common Name CBP20
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >95%
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.